Professional Documents
Culture Documents
50 28 2
50 28 2
Estradiol
E1024 50-28-2 Laboratory chemicals, Manufacture of substances
1.2 2. 2.1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses
HAZARDS IDENTIFICATION Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Carcinogenicity (Category 2) Reproductive toxicity (Category 1A) Effects on or via lactation
2.2
- E1024
May impair fertility. Limited evidence of a carcinogenic effect. Possible risk of harm to the unborn child. May cause harm to breastfed babies. In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible). Avoid exposure - obtain special instructions before use.
2.3 3.
3.1
Substances
Synonyms :
3,17 -Dihydroxy-1,3,5(10)-estratriene -Estradiol 1,3,5-Estratriene- 3,17 -diol Dihydrofolliculin 17 -Estradiol C18H24O2 272,38 g/mol Concentration 50-28-2 200-023-8 -
: :
Estradiol
CAS-No. EC-No.
4. 4.1
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
- E1024
4.2
4.3 5. 5.1
Further information
no data available
ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.
6.2 6.3
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains.
6.4 7. 7.1
EXPOSURE CONTROLS/PERSONAL PROTECTION Control parameters Components with workplace control parameters Exposure controls Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday.
- E1024
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it.
Body Protection
impervious clothing, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU).
9. 9.1
PHYSICAL AND CHEMICAL PROPERTIES Information on basic physical and chemical properties
a) Appearance b) Odour c) Odour Threshold d) pH e) Melting point/freezing point f) Initial boiling point and boiling range g) Flash point h) Evaporation rate i) j) Form: powder Colour: white no data available no data available no data available Melting point/range: 176 - 180 C - lit. no data available no data available no data available
Flammability (solid, gas) no data available Upper/lower no data available flammability or explosive limits k) Vapour pressure no data available l) Vapour density no data available m) Relative density n) Water solubility o) Partition coefficient: noctanol/water p) Autoignition no data available no data available no data available no data available
no data available
9.2
Skin corrosion/irritation
no data available
Carcinogenicity
The National Toxicology Program (Tenth Report on Carcinogens) has determined that steroidal estrogens are known to be human carcinogens based on sufficient evidence of carcinogenicity in humans, which indicates a causal relationship between exposure to steroidal estrogens and human cancer. This is or contains a component that has been reported to be carcinogenic based on its IARC, OSHA, ACGIH, NTP, or EPA classification. Suspected human carcinogens IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Suspected human reproductive toxicant Damage to fetus cannot be excluded.
- E1024
Known human reproductive toxicant Effects on or via lactation May damage fertility. Suspected of damaging the unborn child.
Aspiration hazard
no data available
no data available
Potential health effects Inhalation May be harmful if inhaled. May cause respiratory tract irritation. Ingestion May be harmful if swallowed. Skin May be harmful if absorbed through skin. May cause skin irritation. Eyes May cause eye irritation. Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
Additional Information
RTECS: KG2975000
12.6 Other adverse effects 13. DISPOSAL CONSIDERATIONS 13.1 Waste treatment methods Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.
IMDG: -
IATA: -
15.
REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
16.
See reverse side of invoice or packing slip for additional terms and conditions of sale.